Value of laparoscopic in the staging of pancreatic cancer

Diego Camacho, Dan Reichenbach, Georg D. Duerr, Tammy L. Venema, John F. Sweeney, William E. Fisher

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Pancreatic cancer is a devastating disease that swiftly robs patients of both quality and quantity of life. It is the fourth leading cause of cancer death in the United States. In 2003, there were 31,860 reported new cases with 31,270 deaths occurring due to lack of effective therapy. Eighty percent of patients present with either advanced local or metastatic disease. Dynamic contrast-enhanced computed tomography (CT) has become the current staging test of choice. Laparoscopic staging of pancreatic tumors with the addition of ultrasound can reveal intraparenchymal hepatic metastases, small peritoneal metastases, and critical retroperitoneal tumor-vessel relationships approaching the accuracy of open exploration to determine resectability without significantly increasing morbidity or mortality. However, given the current accuracy of high-quality CT, the routine use of diagnostic laparoscopy in pancreatic cancer is not warranted. Diagnostic laparoscopy is recommended in select patients with primary tumors greater than 4 cm, tumors in the body or tail of the pancreas, patients with equivocal findings of metastasis on CT, ascites, or clinical or laboratory findings suggesting advanced disease such as marked weight loss, hypoalbuminemia, and elevated CA 19-9.

Original languageEnglish (US)
Pages (from-to)552-561
Number of pages10
JournalJournal of the Pancreas
Volume6
Issue number6
StatePublished - Nov 2005
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Tomography
Neoplasm Metastasis
Laparoscopy
Neoplasms
Hypoalbuminemia
Neoplasm Staging
Ascites
Weight Loss
Pancreas
Cause of Death
Quality of Life
Morbidity
Mortality
Liver
Therapeutics

Keywords

  • Laparoscopy
  • Neoplasm staging
  • Pancreatic neoplasms

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Camacho, D., Reichenbach, D., Duerr, G. D., Venema, T. L., Sweeney, J. F., & Fisher, W. E. (2005). Value of laparoscopic in the staging of pancreatic cancer. Journal of the Pancreas, 6(6), 552-561.

Value of laparoscopic in the staging of pancreatic cancer. / Camacho, Diego; Reichenbach, Dan; Duerr, Georg D.; Venema, Tammy L.; Sweeney, John F.; Fisher, William E.

In: Journal of the Pancreas, Vol. 6, No. 6, 11.2005, p. 552-561.

Research output: Contribution to journalArticle

Camacho, D, Reichenbach, D, Duerr, GD, Venema, TL, Sweeney, JF & Fisher, WE 2005, 'Value of laparoscopic in the staging of pancreatic cancer', Journal of the Pancreas, vol. 6, no. 6, pp. 552-561.
Camacho D, Reichenbach D, Duerr GD, Venema TL, Sweeney JF, Fisher WE. Value of laparoscopic in the staging of pancreatic cancer. Journal of the Pancreas. 2005 Nov;6(6):552-561.
Camacho, Diego ; Reichenbach, Dan ; Duerr, Georg D. ; Venema, Tammy L. ; Sweeney, John F. ; Fisher, William E. / Value of laparoscopic in the staging of pancreatic cancer. In: Journal of the Pancreas. 2005 ; Vol. 6, No. 6. pp. 552-561.
@article{97170e213c5d44cfbe8c8ca700f84d55,
title = "Value of laparoscopic in the staging of pancreatic cancer",
abstract = "Pancreatic cancer is a devastating disease that swiftly robs patients of both quality and quantity of life. It is the fourth leading cause of cancer death in the United States. In 2003, there were 31,860 reported new cases with 31,270 deaths occurring due to lack of effective therapy. Eighty percent of patients present with either advanced local or metastatic disease. Dynamic contrast-enhanced computed tomography (CT) has become the current staging test of choice. Laparoscopic staging of pancreatic tumors with the addition of ultrasound can reveal intraparenchymal hepatic metastases, small peritoneal metastases, and critical retroperitoneal tumor-vessel relationships approaching the accuracy of open exploration to determine resectability without significantly increasing morbidity or mortality. However, given the current accuracy of high-quality CT, the routine use of diagnostic laparoscopy in pancreatic cancer is not warranted. Diagnostic laparoscopy is recommended in select patients with primary tumors greater than 4 cm, tumors in the body or tail of the pancreas, patients with equivocal findings of metastasis on CT, ascites, or clinical or laboratory findings suggesting advanced disease such as marked weight loss, hypoalbuminemia, and elevated CA 19-9.",
keywords = "Laparoscopy, Neoplasm staging, Pancreatic neoplasms",
author = "Diego Camacho and Dan Reichenbach and Duerr, {Georg D.} and Venema, {Tammy L.} and Sweeney, {John F.} and Fisher, {William E.}",
year = "2005",
month = "11",
language = "English (US)",
volume = "6",
pages = "552--561",
journal = "Journal of the Pancreas",
issn = "1590-8577",
publisher = "E.S. Burioni Ricerche Bibliografiche",
number = "6",

}

TY - JOUR

T1 - Value of laparoscopic in the staging of pancreatic cancer

AU - Camacho, Diego

AU - Reichenbach, Dan

AU - Duerr, Georg D.

AU - Venema, Tammy L.

AU - Sweeney, John F.

AU - Fisher, William E.

PY - 2005/11

Y1 - 2005/11

N2 - Pancreatic cancer is a devastating disease that swiftly robs patients of both quality and quantity of life. It is the fourth leading cause of cancer death in the United States. In 2003, there were 31,860 reported new cases with 31,270 deaths occurring due to lack of effective therapy. Eighty percent of patients present with either advanced local or metastatic disease. Dynamic contrast-enhanced computed tomography (CT) has become the current staging test of choice. Laparoscopic staging of pancreatic tumors with the addition of ultrasound can reveal intraparenchymal hepatic metastases, small peritoneal metastases, and critical retroperitoneal tumor-vessel relationships approaching the accuracy of open exploration to determine resectability without significantly increasing morbidity or mortality. However, given the current accuracy of high-quality CT, the routine use of diagnostic laparoscopy in pancreatic cancer is not warranted. Diagnostic laparoscopy is recommended in select patients with primary tumors greater than 4 cm, tumors in the body or tail of the pancreas, patients with equivocal findings of metastasis on CT, ascites, or clinical or laboratory findings suggesting advanced disease such as marked weight loss, hypoalbuminemia, and elevated CA 19-9.

AB - Pancreatic cancer is a devastating disease that swiftly robs patients of both quality and quantity of life. It is the fourth leading cause of cancer death in the United States. In 2003, there were 31,860 reported new cases with 31,270 deaths occurring due to lack of effective therapy. Eighty percent of patients present with either advanced local or metastatic disease. Dynamic contrast-enhanced computed tomography (CT) has become the current staging test of choice. Laparoscopic staging of pancreatic tumors with the addition of ultrasound can reveal intraparenchymal hepatic metastases, small peritoneal metastases, and critical retroperitoneal tumor-vessel relationships approaching the accuracy of open exploration to determine resectability without significantly increasing morbidity or mortality. However, given the current accuracy of high-quality CT, the routine use of diagnostic laparoscopy in pancreatic cancer is not warranted. Diagnostic laparoscopy is recommended in select patients with primary tumors greater than 4 cm, tumors in the body or tail of the pancreas, patients with equivocal findings of metastasis on CT, ascites, or clinical or laboratory findings suggesting advanced disease such as marked weight loss, hypoalbuminemia, and elevated CA 19-9.

KW - Laparoscopy

KW - Neoplasm staging

KW - Pancreatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=27944502604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944502604&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 552

EP - 561

JO - Journal of the Pancreas

JF - Journal of the Pancreas

SN - 1590-8577

IS - 6

ER -